In order to investigate the in vivo functional performance of HPPS-mAb, a double-tumor-engrafted mouse model was introduced with CHOvec (TfR-) on the left flank and CHO-hTfR (TfR+) on the right flank. This evidence concerns the gene TFRC and neoplasm.